SEC Comment Letter 0000000000-24-000079 to VOLITIONRX LTD (VNRX)

VOLITIONRX LTD
Date: Jan. 3, 2024 · CIK: 0000093314 · Accession: 0000000000-24-000079

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-36833

Date

January 3, 2024

Author

Terig Hughes

Form

UPLOAD

Company

VOLITIONRX LTD

Letter

United States securities and exchange commission logo January 3, 2024 Terig Hughes Chief Financial Officer VolitionRx Limited 1489 West Warm Springs Road, Suite 110 Henderson, NV 89014 Re:VolitionRx Limited Form 10-K for Fiscal Year Ended December 31, 2022 File No. 001-36833 Dear Terig Hughes: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
January 3, 2024
Terig Hughes
Chief Financial Officer
VolitionRx Limited
1489 West Warm Springs Road, Suite 110
Henderson, NV 89014
Re:VolitionRx Limited
Form 10-K for Fiscal Year Ended December 31, 2022
File No. 001-36833
Dear Terig Hughes:
            We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io